Outlook Therapeutics announces proposed public offering of common stock, warrants

3 hours ago 1

Outlook Therapeutics (NASDAQ:OTLK) said on Thursday that it has commenced an underwritten public offering of its common stock and accompanying warrants exercisable for shares of its common stock.
The company intends to use the net proceeds from the offering for working capital and other general corporate purposes.
OTLK -14.63% after hours to $1.4.
Source: Press Release

Recommended For You